References
- Aurell M, Pettersson M, Berglund G. Renin‐angiotensin system in essential hypertension. Lancet 1975; 2: 342–345
- Bröchner‐Mortenssen J A. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271–274
- Delin K, Aurell M, Granerus G. Preoperative diagnosis of renovascular hypertension. The use of acute stimulation of renin secretion. Acta Med Scand 1984; 215: 363–369
- Eide I, Loyning E, Kiil F. Potentiation of renin release by combining renal arterial constriction and beta‐adrenergic stimulation. Scand J Clin Lab Invest 1974; 34: 301–310
- Esler M D, Jennings G L, Johns J, Burke F, Little P J, Leonard P. Estimation of “total” renal cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. J Hypertension 1984; 2(Suppl 3)123–125
- Giese J, Aurell M, Munck O. Peripheral and renal venous plasma renin concentration in hypertensive patients with unilateral renal or renovascular disease. Scand J Urol Nephrol 1972, Suppl 15: 39–47
- Goldstein D S, McCarty R, Polinsky R, Kopin I. Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 1983; 5: 552–559
- Haugstvedt S, Bjure J, Granerus G. A simple method of background subtraction in two detector renography. Scand J Urol Nephrol 1980; 14: 257–261
- Henriksen J H, Ring‐Larsen Kanstrup I ‐L, Christen‐sen N J. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 1984; 25: 1034–1043
- Hjemdahl P, Daleskog M, Kahaa T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sciences 1979; 25: 131–138
- Ishii M, Ikeda T, Takagi M, Sugimoto T, Atarashi K, Igari T, Vehara Y, Matsuoka H, Hirsta Y, Kimura K, Takeda T, Murao S. Elevated plasma catecholamines in hypertensives with primary glomerular diseases. Hypertension 1983; 5: 545–551
- Januszewicz W, Wocial B. Urinary excretion of catecholamines and their metabolites in patients with renovascular hypertension. Jpn Heart J 1978; 19: 469–478
- Kuylenstierna J. Prostaglandin E2 in hypertension: A clinical study on hormonal concentrations and interrelations in renal venous blood. Thesis, Linköping. 1984
- LaGrange R G, Sloop C H, Schmid H E. Selective stimulation of renal nerves in anesthetized dog. Circ Res 1973; 33: 704–712
- Maslowski A, Nicholls M G, Espiner E A, Ikram H, Bones P J. Mechanisms in human renovascular hypertension. Hypertension 1983; 5: 597–602
- Manhem P, Lecerof H, Hokfelt B. Plasma catechol‐amine levels in the coronary sinus, the left renal vein and peripheral vessels in healthy males at rest and during exercise. Acta Physiol Scand 1978; 104: 364–369
- Norman N, Sundsfjord J A, Stiris G. Effective renal plasma flow (ERPF) of the individual kidney and renal venous renin activity (RV‐RA) determined simultaneously before and after the administration of dihydralazine in renovascular hypertension. Scand J Clin Lab Invest 1975; 35: 219–229
- Oliver J A, Pinto J, Sciacca R R, Cannon P J. Basal norepinephrine overflow into the renal vein: effect of renal nerve stimulation. Am J Physiol 1980; 239: F371–F377
- Renal hypertension, I H Page, J W McCubbin. Year Book Medical Publishers, Chicago 1968
- Pettinger W A, Keeton K. Altered renin release and propranolol potentiation of vasodilatory drug hypotension. J Clin Invest 1975; 55: 236–243
- Ueda H, Kaneko Y, Takeda T, Ikeda T, Yagi S. Observations on the mechanisms of renin release by hydralazine in hypertensive patients. Circ Res 1970; 26/27(Suppl 11)201–206
- Yamaguchi I, Kopin I J. Blood pressure, plasma catecholamines and sympathetic outflow in pithed SHR and WKY rats. Am J Physiol 1980; 238: 365–372